Catalog: | C-FC-1493A |
Product Type: | FCM Antibody |
Size: | 25 μg/50 μg/100 μg/200 μg |
Reactivity: | Mouse |
Analysis mode: | FCM |
Host: | Rat |
Isotype: | Rat IgG2a, κ |
Alternate names: | Endoglin,END,Eng |
Form: | Liquid |
Shipping: | Biological ice pack at 4℃ |
Storage: | 2-8℃ |
Conjugation: | PE |
Buffer: | PBS with 0.05% Proclin300, 1% BSA |
Swiss port: | Q63961 |
Clone NO.: | MJ7/18 |
Recommended use: | Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. Please check your vial before the experiment. Since applications vary, the appropriate dilutions must be determined for individual use. We suggest each investigator should titrate the reagent to obtain optimal results or refer to the dilution we used in the experiment. |
CD105 is a 90 kD homodimeric type I integral membrane glycoprotein, also known as endoglin. It is expressed on endothelial cells (especially on angiogenic endothelial cells) and upregulated by hypoxia, activated monocytes, macrophages, bone marrow stromal cells, and some cytotrophoblasts. CD105 is a receptor for TGF-β1, TGF-β3 and modulates TGF-β signaling by interacting with TGF-β receptors I and/or II. CD105 also binds other growth factors such as actvin A, BMP-2, and BMP-7. CD105 has been show to be a useful marker for identifying proliferating endothelium involved in tumor angiogenesis and can be used for tumor imaging and prognosis, and has therapeutic potential for some solid tumors and other angiogenic diseases.
Copyright © 2024 Creative Biogene. All rights reserved.